Hong Kong Stock Announcement Nuggets | China Biopharmaceutical plans to acquire 5% of Chia Tai Tianqing's shares from Xie Chengrun for 4.48 billion yuan and increase indirect shareholding to 65% after completion

Important matters:

China Biopharmaceutical (01177) plans to acquire 5% of Chia Tai Tianqing's shares from Xie Chengrun for 4.48 billion yuan and increase indirect shareholding to 65% after completion

Junzhi Group (01300): Plans to acquire 100% of Qinghai Zhongli Optical Fiber Technology's shares for 455 million yuan

China Hongqiao (01378) subsidiary plans to acquire all shares of Weiqiao Xinchuang for 240 million yuan

A subsidiary of Fubo Group (03738) signed a cooperation agreement with Ant Mathematics to jointly build a major copyright model

China Party Culture (01532) plans to sell 32% of the total registered capital of Zhejiang Yunyou Smart Cultural Tourism Group

Deshi-B (02526) signed a cooperation framework agreement with Anji to cooperate on artificial intelligence for medical imaging, grass-roots imaging cloud services and medical data products

Operating performance:

Shimao Group (00813)'s cumulative contract sales for the first 8 months were about 9.721 billion yuan

The cumulative contract sales amount of Xincheng Development (01030) in the first 8 months was about 8.107 billion yuan, a year-on-year decrease of 40.24%

R&F Real Estate (02777)'s total sales revenue for the first 8 months was about 8.85 billion yuan, a year-on-year decrease of 5.85%

The cumulative contract sales amount of Zhongliang Holdings (02772) in the first 8 months was about 4.29 billion yuan, a year-on-year decrease of 48.25%

CGN New Energy (01811) completed 1776.3 gigawatt-hours of power generation in August, up 15.1% year-on-year

Times Group Holdings (01023)'s profit warning expects annual shareholders' losses to narrow to about HK$110 million to HK$130 million year-on-year